世界のイソクエン酸デヒドロゲナーゼ阻害剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Isocitrate Dehydrogenase Inhibitors Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4398 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、イソクエン酸デヒドロゲナーゼ阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IDH1変異髄質悪性腫瘍、IDH2変異髄質悪性腫瘍、その他）、用途別市場規模（DH阻害剤、FLT3阻害剤、ヘッジホッグ経路阻害剤、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・イソクエン酸デヒドロゲナーゼ阻害剤の市場動向 ・企業の競争状況、市場シェア ・イソクエン酸デヒドロゲナーゼ阻害剤の種類別市場規模と予測2016-2027（IDH1変異髄質悪性腫瘍、IDH2変異髄質悪性腫瘍、その他） ・イソクエン酸デヒドロゲナーゼ阻害剤の用途別市場規模と予測2016-2027（DH阻害剤、FLT3阻害剤、ヘッジホッグ経路阻害剤、その他） ・イソクエン酸デヒドロゲナーゼ阻害剤の北米市場規模2016-2027（アメリカ、カナダ） ・イソクエン酸デヒドロゲナーゼ阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・イソクエン酸デヒドロゲナーゼ阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・イソクエン酸デヒドロゲナーゼ阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・イソクエン酸デヒドロゲナーゼ阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AGIOS、Aslan Pharmaceuticals、Bayer、Beigene、Bristol-Myers Squibb、Celgene、Daiichi Sankyo、Philogen S.p.A.、Tesaro、Tragara/Adastra、Tocagen） ・結論

Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (α-ketoglutarate) and CO2.
Specific mutations in the isocitrate dehydrogenase gene IDH1 have been found in several brain tumors including astrocytoma, oligodendroglioma and glioblastoma multiforme, with mutations found in nearly all cases of secondary glioblastomas, which develop from lower-grade gliomas, but rarely in primary high-grade glioblastoma multiforme.Patients whose tumor had an IDH1 mutation had longer survival. Furthermore, mutations of IDH2 and IDH1 were found in up to 20% of cytogenetically normal acute myeloid leukemia (AML).These mutations are known to produce (D)-2-hydroxyglutarate from alpha-ketoglutarate.(D)-2-hydroxyglutarate accumulates to very high concentrations which inhibits the function of enzymes that are dependent on alpha-ketoglutarate.This leads to a hypermethylated state of DNA and histones, which results in different gene expression that can activate oncogenes and inactivate tumor-suppressor genes. Ultimately, this may lead to the types of cancer described above.Isocitrate dehydrogenase inhibition technology can be effectively applied to the cancer market.

Market Analysis and Insights: Global Isocitrate Dehydrogenase Inhibitors Market
The global Isocitrate Dehydrogenase Inhibitors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Isocitrate Dehydrogenase Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Isocitrate Dehydrogenase Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Isocitrate Dehydrogenase Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Isocitrate Dehydrogenase Inhibitors market.

Global Isocitrate Dehydrogenase Inhibitors Scope and Market Size
Isocitrate Dehydrogenase Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Isocitrate Dehydrogenase Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
IDH1 Mutant Medullary Malignant Tumor
IDH2 Mutant Medullary Malignant Tumor
Others

Segment by Application
DH Inhibitor
FLT3 Inhibitor
Hedgehog Pathway Inhibitor
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AGIOS
Aslan Pharmaceuticals
Bayer
Beigene
Bristol-Myers Squibb
Celgene
Daiichi Sankyo
Philogen S.p.A.
Tesaro
Tragara/Adastra
Tocagen

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 IDH1 Mutant Medullary Malignant Tumor
1.2.3 IDH2 Mutant Medullary Malignant Tumor
1.2.4 Others
1.3 Market by Application
1.3.1 Global Isocitrate Dehydrogenase Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 DH Inhibitor
1.3.3 FLT3 Inhibitor
1.3.4 Hedgehog Pathway Inhibitor
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Isocitrate Dehydrogenase Inhibitors Market Perspective (2016-2027)
2.2 Isocitrate Dehydrogenase Inhibitors Growth Trends by Regions
2.2.1 Isocitrate Dehydrogenase Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Isocitrate Dehydrogenase Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 Isocitrate Dehydrogenase Inhibitors Industry Dynamic
2.3.1 Isocitrate Dehydrogenase Inhibitors Market Trends
2.3.2 Isocitrate Dehydrogenase Inhibitors Market Drivers
2.3.3 Isocitrate Dehydrogenase Inhibitors Market Challenges
2.3.4 Isocitrate Dehydrogenase Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Isocitrate Dehydrogenase Inhibitors Players by Revenue
3.1.1 Global Top Isocitrate Dehydrogenase Inhibitors Players by Revenue (2016-2021)
3.1.2 Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global Isocitrate Dehydrogenase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Isocitrate Dehydrogenase Inhibitors Revenue
3.4 Global Isocitrate Dehydrogenase Inhibitors Market Concentration Ratio
3.4.1 Global Isocitrate Dehydrogenase Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Isocitrate Dehydrogenase Inhibitors Revenue in 2020
3.5 Isocitrate Dehydrogenase Inhibitors Key Players Head office and Area Served
3.6 Key Players Isocitrate Dehydrogenase Inhibitors Product Solution and Service
3.7 Date of Enter into Isocitrate Dehydrogenase Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Isocitrate Dehydrogenase Inhibitors Breakdown Data by Type
4.1 Global Isocitrate Dehydrogenase Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Type (2022-2027)

5 Isocitrate Dehydrogenase Inhibitors Breakdown Data by Application
5.1 Global Isocitrate Dehydrogenase Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Isocitrate Dehydrogenase Inhibitors Market Size (2016-2027)
6.2 North America Isocitrate Dehydrogenase Inhibitors Market Size by Type
6.2.1 North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021)
6.2.2 North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027)
6.2.3 North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2027)
6.3 North America Isocitrate Dehydrogenase Inhibitors Market Size by Application
6.3.1 North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021)
6.3.2 North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027)
6.3.3 North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2027)
6.4 North America Isocitrate Dehydrogenase Inhibitors Market Size by Country
6.4.1 North America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021)
6.4.2 North America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size (2016-2027)
7.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type
7.2.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2027)
7.3 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application
7.3.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2027)
7.4 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country
7.4.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Type
8.2.1 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Application
8.3.1 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Region
8.4.1 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Isocitrate Dehydrogenase Inhibitors Market Size (2016-2027)
9.2 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type
9.2.1 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2027)
9.3 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application
9.3.1 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2027)
9.4 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country
9.4.1 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type
10.2.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application
10.3.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Country
10.4.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AGIOS
11.1.1 AGIOS Company Details
11.1.2 AGIOS Business Overview
11.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Introduction
11.1.4 AGIOS Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
11.1.5 AGIOS Recent Development
11.2 Aslan Pharmaceuticals
11.2.1 Aslan Pharmaceuticals Company Details
11.2.2 Aslan Pharmaceuticals Business Overview
11.2.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Introduction
11.2.4 Aslan Pharmaceuticals Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
11.2.5 Aslan Pharmaceuticals Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Isocitrate Dehydrogenase Inhibitors Introduction
11.3.4 Bayer Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Beigene
11.4.1 Beigene Company Details
11.4.2 Beigene Business Overview
11.4.3 Beigene Isocitrate Dehydrogenase Inhibitors Introduction
11.4.4 Beigene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
11.4.5 Beigene Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Introduction
11.5.4 Bristol-Myers Squibb Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Isocitrate Dehydrogenase Inhibitors Introduction
11.6.4 Celgene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
11.6.5 Celgene Recent Development
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Details
11.7.2 Daiichi Sankyo Business Overview
11.7.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Introduction
11.7.4 Daiichi Sankyo Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
11.7.5 Daiichi Sankyo Recent Development
11.8 Philogen S.p.A.
11.8.1 Philogen S.p.A. Company Details
11.8.2 Philogen S.p.A. Business Overview
11.8.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Introduction
11.8.4 Philogen S.p.A. Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
11.8.5 Philogen S.p.A. Recent Development
11.9 Tesaro
11.9.1 Tesaro Company Details
11.9.2 Tesaro Business Overview
11.9.3 Tesaro Isocitrate Dehydrogenase Inhibitors Introduction
11.9.4 Tesaro Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
11.9.5 Tesaro Recent Development
11.10 Tragara/Adastra
11.10.1 Tragara/Adastra Company Details
11.10.2 Tragara/Adastra Business Overview
11.10.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Introduction
11.10.4 Tragara/Adastra Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
11.10.5 Tragara/Adastra Recent Development
11.11 Tocagen
11.11.1 Tocagen Company Details
11.11.2 Tocagen Business Overview
11.11.3 Tocagen Isocitrate Dehydrogenase Inhibitors Introduction
11.11.4 Tocagen Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
11.11.5 Tocagen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of IDH1 Mutant Medullary Malignant Tumor
Table 3. Key Players of IDH2 Mutant Medullary Malignant Tumor
Table 4. Key Players of Others
Table 5. Global Isocitrate Dehydrogenase Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Isocitrate Dehydrogenase Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Isocitrate Dehydrogenase Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Isocitrate Dehydrogenase Inhibitors Market Share by Regions (2016-2021)
Table 9. Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Isocitrate Dehydrogenase Inhibitors Market Share by Regions (2022-2027)
Table 11. Isocitrate Dehydrogenase Inhibitors Market Trends
Table 12. Isocitrate Dehydrogenase Inhibitors Market Drivers
Table 13. Isocitrate Dehydrogenase Inhibitors Market Challenges
Table 14. Isocitrate Dehydrogenase Inhibitors Market Restraints
Table 15. Global Isocitrate Dehydrogenase Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Isocitrate Dehydrogenase Inhibitors Market Share by Players (2016-2021)
Table 17. Global Top Isocitrate Dehydrogenase Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Isocitrate Dehydrogenase Inhibitors as of 2020)
Table 18. Ranking of Global Top Isocitrate Dehydrogenase Inhibitors Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Isocitrate Dehydrogenase Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Isocitrate Dehydrogenase Inhibitors Product Solution and Service
Table 22. Date of Enter into Isocitrate Dehydrogenase Inhibitors Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type (2016-2021)
Table 26. Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Isocitrate Dehydrogenase Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Application (2016-2021)
Table 30. Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 62. AGIOS Company Details
Table 63. AGIOS Business Overview
Table 64. AGIOS Isocitrate Dehydrogenase Inhibitors Product
Table 65. AGIOS Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
Table 66. AGIOS Recent Development
Table 67. Aslan Pharmaceuticals Company Details
Table 68. Aslan Pharmaceuticals Business Overview
Table 69. Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product
Table 70. Aslan Pharmaceuticals Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
Table 71. Aslan Pharmaceuticals Recent Development
Table 72. Bayer Company Details
Table 73. Bayer Business Overview
Table 74. Bayer Isocitrate Dehydrogenase Inhibitors Product
Table 75. Bayer Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
Table 76. Bayer Recent Development
Table 77. Beigene Company Details
Table 78. Beigene Business Overview
Table 79. Beigene Isocitrate Dehydrogenase Inhibitors Product
Table 80. Beigene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
Table 81. Beigene Recent Development
Table 82. Bristol-Myers Squibb Company Details
Table 83. Bristol-Myers Squibb Business Overview
Table 84. Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product
Table 85. Bristol-Myers Squibb Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
Table 86. Bristol-Myers Squibb Recent Development
Table 87. Celgene Company Details
Table 88. Celgene Business Overview
Table 89. Celgene Isocitrate Dehydrogenase Inhibitors Product
Table 90. Celgene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
Table 91. Celgene Recent Development
Table 92. Daiichi Sankyo Company Details
Table 93. Daiichi Sankyo Business Overview
Table 94. Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product
Table 95. Daiichi Sankyo Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
Table 96. Daiichi Sankyo Recent Development
Table 97. Philogen S.p.A. Company Details
Table 98. Philogen S.p.A. Business Overview
Table 99. Philogen S.p.A. Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
Table 100. Philogen S.p.A. Recent Development
Table 101. Tesaro Company Details
Table 102. Tesaro Business Overview
Table 103. Tesaro Isocitrate Dehydrogenase Inhibitors Product
Table 104. Tesaro Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
Table 105. Tesaro Recent Development
Table 106. Tragara/Adastra Company Details
Table 107. Tragara/Adastra Business Overview
Table 108. Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product
Table 109. Tragara/Adastra Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
Table 110. Tragara/Adastra Recent Development
Table 111. Tocagen Company Details
Table 112. Tocagen Business Overview
Table 113. Tocagen Isocitrate Dehydrogenase Inhibitors Product
Table 114. Tocagen Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
Table 115. Tocagen Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Isocitrate Dehydrogenase Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. IDH1 Mutant Medullary Malignant Tumor Features
Figure 3. IDH2 Mutant Medullary Malignant Tumor Features
Figure 4. Others Features
Figure 5. Global Isocitrate Dehydrogenase Inhibitors Market Share by Application: 2020 VS 2027
Figure 6. DH Inhibitor Case Studies
Figure 7. FLT3 Inhibitor Case Studies
Figure 8. Hedgehog Pathway Inhibitor Case Studies
Figure 9. Others Case Studies
Figure 10. Isocitrate Dehydrogenase Inhibitors Report Years Considered
Figure 11. Global Isocitrate Dehydrogenase Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Isocitrate Dehydrogenase Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Isocitrate Dehydrogenase Inhibitors Market Share by Regions: 2020 VS 2027
Figure 14. Global Isocitrate Dehydrogenase Inhibitors Market Share by Regions (2022-2027)
Figure 15. Global Isocitrate Dehydrogenase Inhibitors Market Share by Players in 2020
Figure 16. Global Top Isocitrate Dehydrogenase Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Isocitrate Dehydrogenase Inhibitors as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Isocitrate Dehydrogenase Inhibitors Revenue in 2020
Figure 18. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type (2016-2021)
Figure 19. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type (2022-2027)
Figure 20. North America Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Isocitrate Dehydrogenase Inhibitors Market Share by Type (2016-2027)
Figure 22. North America Isocitrate Dehydrogenase Inhibitors Market Share by Application (2016-2027)
Figure 23. North America Isocitrate Dehydrogenase Inhibitors Market Share by Country (2016-2027)
Figure 24. United States Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Isocitrate Dehydrogenase Inhibitors Market Share by Type (2016-2027)
Figure 28. Europe Isocitrate Dehydrogenase Inhibitors Market Share by Application (2016-2027)
Figure 29. Europe Isocitrate Dehydrogenase Inhibitors Market Share by Country (2016-2027)
Figure 30. Germany Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Share by Region (2016-2027)
Figure 40. China Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Isocitrate Dehydrogenase Inhibitors Market Share by Type (2016-2027)
Figure 48. Latin America Isocitrate Dehydrogenase Inhibitors Market Share by Application (2016-2027)
Figure 49. Latin America Isocitrate Dehydrogenase Inhibitors Market Share by Country (2016-2027)
Figure 50. Mexico Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Share by Country (2016-2027)
Figure 56. Turkey Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AGIOS Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
Figure 60. Aslan Pharmaceuticals Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
Figure 61. Bayer Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
Figure 62. Beigene Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
Figure 64. Celgene Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
Figure 65. Daiichi Sankyo Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
Figure 66. Philogen S.p.A. Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
Figure 67. Tesaro Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
Figure 68. Tragara/Adastra Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
Figure 69. Tocagen Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---